speb/financial-data huggingface dataset:
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Other Receivables: 125050000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Other Receivables: 125050000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Other Special Charges: -620000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Otherunder Preferred Stock Dividend: 0.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Payables: 575790000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Payables: 575790000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 18210000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 18210000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Prepaid Assets: 283490000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 283490000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Pretax Income: 106820000.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Pretax Income: 119500000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Properties: 0.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Properties: 0.00
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Provisionand Write Offof Assets: 78240000.00
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Purchase Of Business: 0.00
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Purchase Of Investment: -505130000.00
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Purchase Of PPE: -474580000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Reconciled Cost Of Revenue: 3877050000.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 892130000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Reconciled Depreciation: 621980000.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 164970000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Rent And Landing Fees: 33170000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Rent Expense Supplemental: 33170000.00
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Repayment Of Debt: -352480000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Restricted Cash: 128180000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 128180000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Retained Earnings: -4692800000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -4692800000.00
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Sale Of Investment: 1575770000.00
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Sale Of PPE: 620000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Selling And Marketing Expense: 117810000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Selling General And Administration: 994930000.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Selling General And Administration: 268110000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Share Issued: 79311773.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Share Issued: 79311773.00
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Short Term Debt Issuance: 485340000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Special Income Charges: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Special Income Charges: 0.00
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Stock Based Compensation: 80940000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Stockholders Equity: 5682470000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 5682470000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Tangible Book Value: 2767100000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 2767100000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Tax Provision: -34720000.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Tax Provision: -10660000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Tax Rate For Calcs: 0.30
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.30
CAPILLARY.NS cash_flow (annual, 2025-03-31) — Taxes Refund Paid: -38330000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Total Assets: 8386540000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Total Assets: 8386540000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Total Capitalization: 5695290000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 5695290000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Total Debt: 1064260000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Total Debt: 1064260000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Total Equity Gross Minority Interest: 5682470000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 5682470000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Total Expenses: 5933990000.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Total Expenses: 1410440000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Total Liabilities Net Minority Interest: 2704070000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 2704070000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Total Non Current Assets: 4204320000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 4204320000.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 197110000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 197110000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Total Other Finance Cost: 10170000.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Total Unusual Items: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items: 0.00
CAPILLARY.NS income_statement (annual, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-03-31) — Total Unusual Items Excluding Goodwill: 0.00
CAPILLARY.NS balance_sheet (annual, 2025-03-31) — Working Capital: 1675260000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-03-31) — Working Capital: 1675260000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 724050000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 1851010000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -154000000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 5930480000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Allowance For Doubtful Accounts Receivable: -137570000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Available For Sale Securities: 103520000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Buildings And Improvements: 183790000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 112220000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Capital Stock: 146650000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 603490000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 852580000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Cash Financial: 603490000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Common Stock: 146650000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 5961980000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Current Assets: 3213010000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 50540000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Current Debt: 876070000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 926610000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Current Deferred Assets: 13800000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Current Deferred Taxes Liabilities: 15660000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2733190000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Goodwill: 2910530000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 4400160000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Gross Accounts Receivable: 1988580000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Gross PPE: 299130000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Invested Capital: 6851360000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Investmentin Financial Assets: 103520000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 61680000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 13310000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 74990000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 115340000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Net Debt: 285890000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Net PPE: 145130000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 1561820000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Non Current Accrued Expenses: 0.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 4460000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 6830000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 59040000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Non Current Pension And Other Postretirement Benefit Plans: 94140000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Non Current Prepaid Assets: 151890000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 79311773.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Other Equity Interest: 3180730000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 1489630000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Other Payable: 64440000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Other Receivables: 228620000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 249090000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Payables: 788490000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 19870000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Prepaid Assets: 267000000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Properties: 0.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 0.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -4683850000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Share Issued: 79311773.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 5961980000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 1561820000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Total Assets: 8923340000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 5975290000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Total Debt: 1001600000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 5961980000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2961360000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 5710330000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 228170000.00
CAPILLARY.NS balance_sheet (quarterly, 2025-09-30) — Working Capital: 479820000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — +Operating Expense: 555560000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — +Total Revenue: 1840350000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Basic Average Shares: 76104762.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Basic EPS: 1.05
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 1225840000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Depreciation And Amortization In Income Statement: 190800000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Depreciation Income Statement: 190800000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 76836538.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.04
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 79910000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — EBIT: 95780000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — EBITDA: 286580000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 203810000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Gross Profit: 614510000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Interest Expense: 14590000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 14590000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Net Income: 79910000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 79910000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 79910000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Net Income Discontinuous Operations: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 79910000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 79910000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 79910000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Net Interest Income: -14590000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -14590000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 286580000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Normalized Income: 79910000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Operating Income: 58950000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Operating Revenue: 1840350000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 36830000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Other Operating Expenses: 160950000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Otherunder Preferred Stock Dividend: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Pretax Income: 81190000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 1225840000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 190800000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Selling General And Administration: 203810000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Special Income Charges: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Tax Provision: 1280000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.02
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Total Expenses: 1781400000.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items: 0.00
CAPILLARY.NS income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: 0.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — +Operating Expense: 2336420000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — +Operating Expense: 572010000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — +Total Revenue: 7345990000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — +Total Revenue: 1913460000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Accounts Payable: 743840000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 743840000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Accounts Receivable: 1808350000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 1808350000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Available For Sale Securities: 390770000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Available For Sale Securities: 390770000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Basic Average Shares: 79276051.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Basic EPS: 5.47
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Beginning Cash Position: 2044990000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Capital Expenditure: -3626140000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Capital Lease Obligations: 88860000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Capital Lease Obligations: 88860000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Capital Stock: 158810000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Capital Stock: 158810000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Cash And Cash Equivalents: 358110000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 358110000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4929900000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 4929900000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Change In Other Current Assets: 82360000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Change In Other Current Liabilities: 303130000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Change In Payable: 247170000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Change In Receivables: -252040000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Change In Working Capital: 437140000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Changes In Cash: -1935370000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Common Stock: 158810000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Common Stock: 158810000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Common Stock Equity: 10234930000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 10234930000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Common Stock Issuance: 3450900000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Cost Of Revenue: 4830770000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 1222670000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Current Assets: 7209860000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Current Assets: 7209860000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Current Capital Lease Obligation: 48520000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Current Capital Lease Obligation: 48520000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Current Debt: 447210000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Current Debt: 447210000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Current Debt And Capital Lease Obligation: 495730000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 495730000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Current Liabilities: 2574210000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 2574210000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Current Provisions: 31060000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Current Provisions: 31060000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Depreciation: 749710000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Depreciation And Amortization: 749710000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Depreciation And Amortization In Income Statement: 749710000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Depreciation And Amortization In Income Statement: 195210000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Depreciation Income Statement: 749710000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Depreciation Income Statement: 195210000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 80303704.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Diluted EPS: 5.40
CAPILLARY.NS income_statement (annual, 2026-03-31) — Diluted NI Availto Com Stockholders: 523880000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 433640000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — EBIT: 565740000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — EBIT: 435440000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — EBITDA: 1315450000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — EBITDA: 630650000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Effect Of Exchange Rate Changes: 242820000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — End Cash Position: 352440000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Financing Cash Flow: 2705010000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Free Cash Flow: -2127070000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Gain Loss On Investment Securities: -16300000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Gain Loss On Sale Of PPE: -30000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — General And Administrative Expense: 1076590000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — General And Administrative Expense: 258170000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Goodwill: 3095760000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Goodwill: 3095760000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Goodwill And Other Intangible Assets: 4481330000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 4481330000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Gross PPE: 120410000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Gross PPE: 120410000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Gross Profit: 2515220000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Gross Profit: 690790000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Interest Expense: 54640000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Interest Expense: 10690000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Interest Expense Non Operating: 54640000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 10690000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Interest Paid Cff: -35520000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Interest Received Cfi: 66000000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Invested Capital: 10682140000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Invested Capital: 10682140000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Investing Cash Flow: -6139450000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Investmentin Financial Assets: 390770000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Investmentin Financial Assets: 390770000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Issuance Of Capital Stock: 3450900000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Long Term Capital Lease Obligation: 40340000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Long Term Capital Lease Obligation: 40340000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Long Term Debt: 0.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 0.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 40340000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 40340000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Long Term Debt Payments: -13540000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Long Term Provisions: 125570000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Long Term Provisions: 125570000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Net Business Purchase And Sale: -1472330000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Net Common Stock Issuance: 3450900000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Net Debt: 89100000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Net Debt: 89100000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Net Foreign Currency Exchange Gain Loss: 48920000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Net Income: 523880000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Net Income: 433640000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Net Income Common Stockholders: 523880000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 433640000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Net Income Continuous Operations: 523880000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 433640000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Net Income Discontinuous Operations: 0.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Net Income Discontinuous Operations: 0.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 523880000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 433640000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 523880000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 433640000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Net Income From Continuing Operations: 511100000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Net Income Including Noncontrolling Interests: 523880000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 433640000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Net Interest Income: -54640000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Net Interest Income: -10690000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Net Investment Purchase And Sale: -1107550000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Net Issuance Payments Of Debt: -510820000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Net Long Term Debt Issuance: -13540000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Net Non Operating Interest Income Expense: -54640000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -10690000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Net PPE: 120410000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Net PPE: 120410000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Net PPE Purchase And Sale: -3625570000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Net Short Term Debt Issuance: -497280000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Net Tangible Assets: 5753600000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 5753600000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Assets: 16270000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 16270000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Non Current Deferred Taxes Liabilities: 27370000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 27370000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Normalized EBITDA: 1065850000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 381050000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Normalized Income: 374120000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Normalized Income: 283880000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Operating Cash Flow: 1499070000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Operating Income: 178800000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Operating Income: 118780000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Operating Revenue: 7345990000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Operating Revenue: 1913460000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Ordinary Shares Number: 79407303.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 79407303.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Other Current Assets: 471610000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 471610000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Other Current Liabilities: 1038950000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Other Current Liabilities: 1038950000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Other Equity Interest: 10076120000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Other Equity Interest: 10076120000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Other Intangible Assets: 1385570000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 1385570000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Other Non Cash Items: -293700000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Other Non Current Assets: 649380000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 649380000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Other Non Operating Income Expenses: 137340000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 67060000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Other Operating Expenses: 510120000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Other Operating Expenses: 118630000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Other Properties: 120410000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Other Properties: 120410000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Other Short Term Investments: 4571790000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 4571790000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Otherunder Preferred Stock Dividend: 0.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Payables: 787920000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Payables: 787920000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Pretax Income: 511100000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Pretax Income: 424750000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Provisionand Write Offof Assets: 16800000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Purchase Of Business: -1472330000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Purchase Of Investment: -1357150000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Purchase Of PPE: -3626140000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Reconciled Cost Of Revenue: 4830770000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 1222670000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Reconciled Depreciation: 749710000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 195210000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Repayment Of Debt: -510820000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Sale Of Investment: 249600000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Sale Of PPE: 570000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Selling General And Administration: 1076590000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Selling General And Administration: 258170000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Share Issued: 79407303.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Share Issued: 79407303.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Short Term Debt Payments: -497280000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Special Income Charges: 249600000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Special Income Charges: 249600000.00
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Stock Based Compensation: 107290000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Stockholders Equity: 10234930000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 10234930000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Tangible Book Value: 5753600000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 5753600000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Tax Effect Of Unusual Items: 99840000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 99840000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Tax Provision: -12780000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Tax Provision: -8890000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Tax Rate For Calcs: 0.40
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.40
CAPILLARY.NS cash_flow (annual, 2026-03-31) — Taxes Refund Paid: -63220000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Total Assets: 13002420000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Total Assets: 13002420000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Total Capitalization: 10234930000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 10234930000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Total Debt: 536070000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Total Debt: 536070000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Total Equity Gross Minority Interest: 10234930000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 10234930000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Total Expenses: 7167190000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Total Expenses: 1794680000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Total Liabilities Net Minority Interest: 2767490000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 2767490000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Total Non Current Assets: 5792560000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 5792560000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 193280000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 193280000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Total Tax Payable: 44080000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 44080000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Total Unusual Items: 249600000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items: 249600000.00
CAPILLARY.NS income_statement (annual, 2026-03-31) — Total Unusual Items Excluding Goodwill: 249600000.00
CAPILLARY.NS income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: 249600000.00
CAPILLARY.NS balance_sheet (annual, 2026-03-31) — Working Capital: 4635650000.00
CAPILLARY.NS balance_sheet (quarterly, 2026-03-31) — Working Capital: 4635650000.00
CAPITALSFB.NS cash_flow (annual, 2022-03-31) — Issuance Of Debt: 226200000.00
CAPITALSFB.NS cash_flow (annual, 2022-03-31) — Long Term Debt Issuance: 226200000.00
CAPITALSFB.NS cash_flow (annual, 2022-03-31) — Long Term Debt Payments: -1409100000.00
CAPITALSFB.NS cash_flow (annual, 2022-03-31) — Net Other Investing Changes: 10000.00
CAPITALSFB.NS cash_flow (annual, 2022-03-31) — Repayment Of Debt: -1409100000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — +Operating Expense: 2227538000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — +Total Revenue: 3714483000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 58899000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -1204588000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 2276445000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 45042520.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Basic EPS: 20.78
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 3975298000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -197644000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 342525000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 9301543000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Federal Funds Sold: 9301543000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -34234000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 0.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 1052992000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: -494479000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: 75446000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: -641322000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Changes In Cash: 944083000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Common Stock: 342525000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Common Stock Dividend Paid: -34234000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 6106107000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Common Stock Issuance: 19855000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Depreciation: 206670000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 206670000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 206670000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 206670000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 45042520.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Diluted EPS: 20.78
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 935962000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — End Cash Position: 4919381000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: 2215154000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 551188000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Gain Loss On Sale Of PPE: -103000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Gain On Sale Of Security: -8655000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 7571000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 2030518000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Insurance And Claims: 82335000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Interest Expense: 3540237000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Interest Income: 6760075000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 13319940000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -2019903000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 14885810000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Investments And Advances: 14885810000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 19855000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 2229533000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 7213833000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 2229533000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 0.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 19855000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Net Income: 935962000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 935962000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 935962000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Net Income Extraordinary: 0.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 935962000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 935962000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 1241564000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 935962000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Net Interest Income: 3219838000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -1823272000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 2229533000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: 2229533000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Net PPE: 825930000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -196631000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 6106107000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Normalized Income: 935884352.87
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 748832000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Operating Revenue: 3714483000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 45042520.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 455540000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Other Payable: 358275000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Other Properties: 1922877000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Other Special Charges: -103000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Payables: 417174000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 277000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Pretax Income: 1241548000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Properties: 107641000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 245484000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -1823272000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -197644000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Receivables: 368725000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 206670000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 275742000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 2331819000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 1013000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 10422000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 17993000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Share Issued: 45042520.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Special Income Charges: 103000.00
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 26709000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 6106107000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 6106107000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 25352.87
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Tax Provision: 305600000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.25
CAPITALSFB.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -343568000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Total Assets: 79907747000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 13319940000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Total Debt: 7213833000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 6106107000.00
CAPITALSFB.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 73801640000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 103000.00
CAPITALSFB.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 103000.00
CAPITALSFB.NS income_statement (annual, 2024-03-31) — +Operating Expense: 2583288000.00
CAPITALSFB.NS income_statement (annual, 2024-03-31) — +Total Revenue: 4131050000.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 63616000.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -1369167000.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 6948673000.00
CAPITALSFB.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 36387519.00
CAPITALSFB.NS income_statement (annual, 2024-03-31) — Basic EPS: 30.65
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 4919381000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -184539000.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 450425000.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 13591176000.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Federal Funds Sold: 13591176000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -42421000.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 0.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 1033866000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: 37550000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 495516000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -211468000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 1731279000.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Common Stock: 450425000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Common Stock Dividend Paid: -42421000.00
CAPITALSFB.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 11974177000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 5005337000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Depreciation: 169029000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 169029000.00
CAPITALSFB.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 169029000.00
CAPITALSFB.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 169029000.00
CAPITALSFB.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 36627325.00
CAPITALSFB.NS income_statement (annual, 2024-03-31) — Diluted EPS: 30.45
CAPITALSFB.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 1115253000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — End Cash Position: 6650660000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: 2225819000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 974366000.00
CAPITALSFB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: -1227000.00